Menu
Not yet recruiting NCT07575126

Comparison of Qigong and Otago in Patient With Diabetic Neuropathy

No phase Interventional Diabetic Neuropathies

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Qigong Balance, Otago Balance.
Who it may be relevant to
Registry conditions: Diabetic Neuropathies. Basic parameters: 45 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparison of Qigong and Otago on Agility, Balance, Gait, and Quality of Life in Patients With Diabetic Neuropathy

Overview

This study seeks to compare these two interventions to better understand their impact on key health outcomes in patients affected by diabetic neuropathy, providing valuable insights for clinicians and healthcare providers managing this challenging condition

Interventions

  • Other Qigong Balance
    Quigong Balance Exercises 3 times per week for 60 minutes per session Open the Flow: Focus on fluid arm movements to enhance relaxation and improve circulation. Shaking Exercise: A full-body shake to release tension and promote energy flow. Lifting the Ball: Alternating arm movements simulating lifting a ball to improve upper body strength and coordination. Playing with Water: Slow, flowing movements that enhance balance and mindfulness. Weight Shifting and Balance Exercises: Stand with feet
  • Other Otago Balance
    Otago (Strengthening) Balance: Sit-to-stand exercises: to improve leg strength. Heel raises: to enhance calf strength. Toe stands: for improving foot stability. Balance Training: Single-leg stands: to enhance balance. Tandem walking: along a straight line. Side leg raises: to strengthen hip muscles 3 times per week for 60 minutes per session

Primary outcome measures

  • Agility T-Test [Time frame: 12th week]
  • Berg Balance Scale [Time frame: 12th week]
  • Functional Reach Test [Time frame: 12th week]
  • Gait Speed Test [Time frame: 12th week]
  • 10-Meter Walk Test [Time frame: 12th week]

Eligibility criteria

Inclusion criteria

  • Physician-diagnosed type 2 diabetes without gender bias, with peripheral neuropathy (defined by Michigan Neuropathy Screening Instrument questionnaire score of 5 or greater)
  • Type 2 diabetic peripheral neuropathy patients
  • The ability to walk independently for 10 m
  • Having score between 46 to 52 (out of a total of 56 points) on the BBS

Exclusion criteria

  • Fracture of the lower limb within the 6 months before the study (15)
  • Diabetic ulcer, infection or partial amputation in feet (15)
  • Disease or functional impairment of auditory, vestibular system (16)
  • Any other medical conditions that would confound assessment of neuropathy such as malignancy, other neurological or orthopedic impairments (such as stroke, poliomyelitis, rheumatoid arthritis, prosthesis, or severe osteoarthritis), major vascular complications (venous or arterial ulcers), severe retinopathy, or severe nephropathy that causes edema or needs hemodialysis (17)
  • Dementia or inability to give consistent information (18)
  • History of surgical procedure at the knee, ankle, or hip or indication of surgery throughout the intervention period

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • DHQ Gujranwala — Guiranwala

Identifiers

NCT: NCT07575126 · REC/RCR &AHS/24/0297

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗